Compare TBBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBBK | LMAT |
|---|---|---|
| Founded | 1999 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 1.9B |
| IPO Year | 2004 | 2006 |
| Metric | TBBK | LMAT |
|---|---|---|
| Price | $68.94 | $83.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $69.33 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 540.5K | 180.6K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | 21.10 | ★ 27.40 |
| EPS | ★ 4.78 | 2.32 |
| Revenue | ★ $523,163,000.00 | $240,866,000.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | $7.37 | $9.07 |
| P/E Ratio | ★ $14.61 | $36.11 |
| Revenue Growth | 10.84 | ★ 13.07 |
| 52 Week Low | $40.51 | $71.42 |
| 52 Week High | $81.65 | $105.55 |
| Indicator | TBBK | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.44 | 43.58 |
| Support Level | $66.85 | $83.33 |
| Resistance Level | $72.00 | $88.28 |
| Average True Range (ATR) | 1.90 | 2.19 |
| MACD | 0.26 | 0.11 |
| Stochastic Oscillator | 47.98 | 17.67 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.